Skip to content
- What are the most robust sensitive or critical effects, adverse or that can progress to adverse, and considered relevant to humans?
- Are we using the appropriate experimental animal species and outcomes?
- How should human epidemiology data be used, including evidence for associations with various health effects and the exposure levels at which these associations occur?
- What are the considerations for choice of uncertainty or safety factors applied to the point(s) of departure for the critical effect?